El dispositivo temporal iTind reduce un 52% los síntomas de la hiperplasia benigna de próstata y preserva la salud funcional – iSanidad
A minimally invasive medical procedure utilizing the iTind temporary implant has demonstrated a 52% reduction in symptoms associated with benign prostatic hyperplasia (BPH) while preserving sexual and ejaculatory function, according to clinical data published in the Journal of Endourology. The device, which uses a non-surgical, wire-based stent to reshape the prostatic urethra, offers an alternative … Read more